J. Bielavský

448 total citations
21 papers, 399 citations indexed

About

J. Bielavský is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, J. Bielavský has authored 21 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Molecular Biology and 9 papers in Organic Chemistry. Recurrent topics in J. Bielavský's work include Cholinesterase and Neurodegenerative Diseases (12 papers), Pesticide Exposure and Toxicity (7 papers) and Computational Drug Discovery Methods (5 papers). J. Bielavský is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (12 papers), Pesticide Exposure and Toxicity (7 papers) and Computational Drug Discovery Methods (5 papers). J. Bielavský collaborates with scholars based in Czechia. J. Bielavský's co-authors include Jiřı́ Cabal, Kamil Kuča, Jiřı́ Kassa, Jiří Patočka, Josef Fusek, J Bajgar, M. Večeřa, Jiří Bajgar and Jaromír Kaválek and has published in prestigious journals such as FEBS Letters, Biochemical Pharmacology and Tetrahedron Letters.

In The Last Decade

J. Bielavský

21 papers receiving 344 citations

Peers

J. Bielavský

PHARM

HTM

Andris Kaminskis United States

Suzana Berend Croatia

M. Vandekar United Kingdom

David L. Stitcher United States

Maja Čalić Croatia

Yukimasa Matsuda Japan

N. Aurbek Germany

Julius M. Coon United States

Tamara Zorbaz Croatia

Martine Polhuijs Netherlands

Andris Kaminskis United States

J. Bielavský

328 ×1.1

188 ×0.7

PHARM

98 ×0.7

116 ×1.1

HTM

13 ×0.2

Citations per year, relative to J. Bielavský J. Bielavský (= 1×) peers Andris Kaminskis

Countries citing papers authored by J. Bielavský

Since Specialization

Citations

This map shows the geographic impact of J. Bielavský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bielavský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bielavský more than expected).

Fields of papers citing papers by J. Bielavský

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bielavský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bielavský. The network helps show where J. Bielavský may publish in the future.

Co-authorship network of co-authors of J. Bielavský

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bielavský. A scholar is included among the top collaborators of J. Bielavský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bielavský. J. Bielavský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuča, Kamil, J. Bielavský, Jiřı́ Cabal, & Jiřı́ Kassa. (2003). Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorganic & Medicinal Chemistry Letters. 13(20). 3545–3547. 118 indexed citations

Kuča, Kamil, et al.. (2003). Synthesis of a potential reactivator of acetylcholinesterase—1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)propane dibromide. Tetrahedron Letters. 44(15). 3123–3125. 105 indexed citations

Patočka, Jiří, J. Bielavský, Jiřı́ Cabal, & Josef Fusek. (2000). 3-Nitropropionic Acid and Similar Nitrotoxins. Acta Medica (Hradec Kralove Czech Republic). 43(1). 9–13. 18 indexed citations

Kassa, Jiřı́ & J. Bielavský. (1999). A Comparison of the Efficacy of New Monopyridinium Oximes with the Oxime HI-6 Against Mevinphos in Mice. Acta Medica (Hradec Kralove Czech Republic). 42(1). 9–11. 1 indexed citations

Bielavský, J., et al.. (1998). ChemInform Abstract: Cholinesterase Reactivators Derived from Pyridine‐2‐carbaldoxime.. ChemInform. 29(25). 2 indexed citations

Bielavský, J., et al.. (1998). Cholinesterase Reactivators Derived from Pyridine-2-carbaldoxime. Collection of Czechoslovak Chemical Communications. 63(2). 199–204. 18 indexed citations

Kassa, Jiřı́ & J. Bielavský. (1997). The Efficacy of Monopyridinium (2‐PAAM, 2‐PAEM) and Bispyridinium (Obidoxime, HI‐6) Oximes against Mevinphos in Mice. Pharmacology & Toxicology. 81(3). 144–146. 7 indexed citations

Bielavský, J., et al.. (1991). [Biotransformation of the anticholinesterase agent, 9-amino-7-methoxy-1,2,3,4-tetrahydroacridine].. PubMed. 40(3). 130–2. 1 indexed citations

Patočka, Jiří, Jiří Bajgar, & J. Bielavský. (1980). Kinetics of inhibition of acetylcholinesterase by 9-hydrazino-1,2,3,4-tetrahydroacridine and 9-amino-10-methyl-1,2,3,4-tetrahydroacridinium in vitro. Collection of Czechoslovak Chemical Communications. 45(3). 966–976. 3 indexed citations

10.

Bielavský, J.. (1977). Analogues of 9-amino-1,2,3,4-tetrahydroacridine. Collection of Czechoslovak Chemical Communications. 42(9). 2802–2808. 17 indexed citations

11.

Patočka, Jiří, J Bajgar, J. Bielavský, & Josef Fusek. (1976). Kinetics of inhibition of cholinesterases by 1,2,3,4-tetrahydro-9-aminoacridine in vitro. Collection of Czechoslovak Chemical Communications. 41(3). 816–824. 28 indexed citations

12.

Patočka, Jiří, J Bajgar, Josef Fusek, & J. Bielavský. (1976). Protective effect of 1,2,3,4-tetrahydro-9-aminoacridine on acetylcholinesterase inhibition by organophosphorus inhibitors. Collection of Czechoslovak Chemical Communications. 41(9). 2646–2649. 7 indexed citations

13.

Patočka, Jiří, et al.. (1973). Kinetics of hydrolysis of acetylthiocholine by oximes. Collection of Czechoslovak Chemical Communications. 38(12). 3685–3693. 3 indexed citations

14.

Bielavský, J., et al.. (1973). Quaternary pyridinedialdoximes as a new type of cholinesterase reactivators. Collection of Czechoslovak Chemical Communications. 38(9). 2788–2792. 2 indexed citations

15.

Patočka, Jiří & J. Bielavský. (1972). Reactivation of isopropyl-methylphosphonylated acetylcholinesterase by α,ω-bis-(4-hydroxyimino- methylpyridinium)-2-trans-butene dibromide—The effect of pH. Biochemical Pharmacology. 21(5). 742–745. 2 indexed citations

16.

Patočka, Jiří & J. Bielavský. (1972). Affinity of bis-quaternary pyridinedialdoximes for the active centre of intact and isopropylmethylphophonylated acetylcholinesterase. Collection of Czechoslovak Chemical Communications. 37(6). 2110–2116. 16 indexed citations

17.

Bielavský, J., et al.. (1972). Preparation and properties of cholinesterase reactivators of bis-quaternary monopyridinaldoxime type. Collection of Czechoslovak Chemical Communications. 37(3). 1044–1048. 9 indexed citations

18.

Patočka, Jiří, et al.. (1970). Reactivating effect of α,ω‐bis‐(4‐pyridinealdoxime)‐2‐trans‐butene dibromide on isopropyl‐methylphosphonylated acetylcholinesterase. FEBS Letters. 10(3). 182–184. 21 indexed citations

19.

Bielavský, J., et al.. (1968). Protonierung mehrsättiger organischer Basen IV. Über die Addition des ersten Protons an 4-substituierte 1,2-Phenylendiamine. Collection of Czechoslovak Chemical Communications. 33(9). 2902–2910. 5 indexed citations

20.

Bielavský, J., et al.. (1968). Protonation of polyacid organic bases. III. Hammett acidity function H+ for aqueous sulfuric acid. Collection of Czechoslovak Chemical Communications. 33(6). 1687–1692. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact